Value8 N.V. (AMS:VALUE)

Market Cap	58.58M
Revenue (ttm)	8.21M
Net Income (ttm)	4.60M
Shares Out	9.60M
EPS (ttm)	0.48
PE Ratio	12.83
Forward PE	n/a
Dividend	0.20 (3.28%)
Ex-Dividend Date	Jul 7, 2025

Volume	5,077
Average Volume	1,923
Open	6.30
Previous Close	6.20
Day's Range	6.10 - 6.35
52-Week Range	5.55 - 6.90
Beta	0.22
RSI	42.71
Earnings Date	n/a

About Blueprint Medicines

Value8 N.V. is a private equity firm specializing in middle market, buyout, add-on and growth capital investments in small and medium-sized companies. The firm primarily invests in the food, healthcare, business and financial services, energy, safety and security, water and environment, leisure, luxury products and internet sectors. It typically invests in Western Europe, primarily in the Netherlands, Belgium and France. The firm considers investments in companies with an enterprise value between €10 million ($10.74 million) and €150 million ($...

• Industry: Asset Management
• Sector: Financials
• Founded: 2008
• Employees: 909
• Stock Exchange: Euronext Amsterdam
• Ticker Symbol: VALUE

Financial Performance

In 2024, Value8's revenue was 9.32 million, an increase of 15.77% compared to the previous year's 8.05 million. Earnings were 7.14 million, an increase of 22.61%.